David Price
Auto-generated profile, based on publicly available information

David Price

Observational and Pragmatic Research Institute, Singapore, Singapore

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2008 in Allergy
Verified
Journal Article
Open access
PDF file
JBJ. Bousquet
J. Bousquet
NKN. Khaltaev
N. Khaltaev
ACA. A. Cruz
A. A. Cruz
JDJ. Denburg
J. Denburg
WFW. J. Fokkens
W. J. Fokkens
DWD. Williams
D. Williams

1 October 2017 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
JBJan L. Brożek
Jan L. Brożek
JBJean Bousquet
Jean Bousquet
IAIoana Agache
Ioana Agache
AAArnav Agarwal
Arnav Agarwal
CBClaus Bachert
Claus Bachert
HSHolger J. Schünemann
Holger J. Schünemann
Allergic rhinitis (AR) affects 10% to 40% of the population. It reduces quality of life and school and work performance and is a frequent reason for office visits in general practice. Medical costs are large, but avoidable costs associated with lost work productivity are even larger than those incurred by asthma. New evidence has accumulated since the last revision of the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines in 2010, prompting its update. We sought to provide a targeted update of the ARIA guidelines. The ARIA guideline panel identified new clinical questions and selected questions requiring an update. We performed systematic reviews of health effects and the evidence about patients' values and preferences and resource requirements (up to June 2016). We followed the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) evidence-to-decision frameworks to develop recommendations. The 2016 revision of the ARIA guidelines provides both updated and new recommendations about the pharmacologic treatment of AR. Specifically, it addresses the relative merits of using oral H1-antihistamines, intranasal H1-antihistamines, intranasal corticosteroids, and leukotriene receptor antagonists either alone or in combination. The ARIA guideline panel provides specific recommendations for the choice of treatment and the rationale for the choice and discusses specific considerations that clinicians and patients might want to review to choose the management most appropriate for an individual patient. Appropriate treatment of AR might improve patients' quality of life and school and work productivity. ARIA recommendations support patients, their caregivers, and health care providers in choosing the optimal treatment.

1 March 2012 in Rhinology journal
Verified
Journal Article
Closed access
WFW.J. Fokkens
W.J. Fokkens
VLV.J. Lund
V.J. Lund
JMJ. Mullol
J. Mullol
CBC. Bachert
C. Bachert
IAI. Alobid
I. Alobid
PWP.J. Wormald
P.J. Wormald
The European Position Paper on Rhinosinusitis and Nasal Polyps 2012 is the update of similar evidence based position papers published in 2005 and 2007. The document contains chapters on definitions and classification, we now also propose definitions for 'difficult to treat' rhinosinusitis, control of disease and better definitions for rhinosinusitis in children. More emphasis is placed on the diagnosis and treatment of acute rhinosinusitis. Throughout the document the terms chronic rhinosinusitis without nasal polyps (CRSsNP) and chronic rhinosinusitis with nasal polyps (CRSwNP) are used to further point out differences in pathophysiology and treatment of these two entities. There are extensive chapters on epidemiology and predisposing factors, inflammatory mechanisms, (differential) diagnosis of facial pain, genetics, cystic fibrosis, aspirin exacerbated respiratory disease, immunodeficiencies, allergic fungal rhinosinusitis and the relationship between the upper and lower airways. The chapters on paediatric acute and chronic rhinosinusitis are totally rewritten. Last but not least all available evidence for management of acute rhinosinusitis and chronic rhinosinusitis with or without nasal polyps in adults and children is analyzed and presented and management schemes based on the evidence are proposed. This executive summary for otorhinolaryngologists focuses on the most important changes and issues for otorhinolaryngologists.

1 November 2015 in The Lancet Respiratory Medicine
Verified
Journal Article
Closed access
DPDavid B Price
David B Price
ARAnna Rigazio
Anna Rigazio
JCJonathan D Campbell
Jonathan D Campbell
EBEugene R Bleecker
Eugene R Bleecker
CCChristopher J Corrigan
Christopher J Corrigan
IPIan D Pavord
Ian D Pavord

4 November 2011 in Allergy
Verified
Journal Article
Closed access
PDF file
PBPhilippe Jean Bousquet
Philippe Jean Bousquet
LHL. Heinzerling
L. Heinzerling
CBC. Bachert
C. Bachert
NPNikolaos Papadopoulos
Nikolaos Papadopoulos
PBPhilippe Jean Bousquet
Philippe Jean Bousquet
PDPascal Demoly
Pascal Demoly

12 June 2014 in npj Primary Care Respiratory Medicine
Verified
Journal Article
Open access
DPDavid Price
David Price
MFMonica Fletcher
Monica Fletcher
TMThys van der Molen
Thys van der Molen
Npj Primary Care Respiratory Medicine is the only fully indexed scientific journal devoted to the management of respiratory diseases in primary care. It is the official journal of PCRS-UK and the IPCRG.